Filing Details

Accession Number:
0001415889-24-029754
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-18 17:00:05
Reporting Period:
2024-12-16
Accepted Time:
2024-12-18 17:00:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551152 Abbvie Inc. ABBV Pharmaceutical Preparations (2834) 320375147
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1968528 K Kevin Buckbee 1 N. Waukegan Road
North Chicago IL 60064
Svp, Controller No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2024-12-16 1,800 $93.50 8,783 No 4 M Direct
Common Stock, $0.01 Par Value Disposition 2024-12-16 1,800 $172.24 6,983 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to buy) Disposition 2024-12-16 1,800 $93.50 1,800 $93.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,111 2021-02-20 2030-02-19 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.